Rheumatoid Arthritis

Chronotherapy with Glucorticoids in Rheumatoid Arthritis

Frank Buttgereit, MD | January 17, 2011

Time is of the essence in balancing risks and benefits

Naturally Occurring Antibodies May Lead to New RA Therapies

From the College | December 1, 2010

A study published in the Journal of Immunology indicates that naturally occurring antibodies in the human immune system have the capacity to suppress inflammatory responses throughout the body. These antibodies may provide researchers an opportunity to develop new therapies for rheumatoid arthritis (RA) and other inflammatory conditions using similar pathways.

Immunizations and Autoimmune Disease

Vanessa Caceres | December 1, 2010

What is safe and what to avoid in this patient population

No Clear Connection Between Inflammation & Disease Progression in AS

Kathy Holliman | October 1, 2010

TNF blockers decrease symptoms but seem to have little impact on structural damage

Research on IL-17 Cytokine May Lead to Novel Therapies for RA

From the College | October 1, 2010

Research in the laboratory of John D. Mountz, MD, PhD, is opening up a whole new field of study in rheumatoid arthritis (RA).

Are We Playing It Safe?

Anja Strangfeld, MD, and Angela Zink, PhD | October 1, 2010

Tumor necrosis factor alpha inhibition and the risk of solid malignancies

Unique Meeting Accelerates RA Research

From the College | September 1, 2010

More than 50 rheumatoid arthritis (RA) investigators from across the U.S. recently met in Ft. Worth, Texas, to share information, present data and results from their innovative RA research projects, and brainstorm ways to work more closely together to find a cure for the disease.